Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Stephenson Cancer Center Aims for NCI Designation

August 21st 2015

Brentuximab Vedotin Label Expanded, Top-Line Results for CLL, NSCLC, and More

August 21st 2015

Explosion in Next-Generation Agents on Horizon in NSCLC

July 31st 2015

Highly effective next-generation therapies are currently in development for patients with oncogene-driven nonâ€“small cell lung cancer, specifically those with alterations in EGFR, ALK, ROS1, NTRK, or a variety of other gene.

Investigational Targeted Therapies for Breast Cancer

July 21st 2015

PARP Inhibitors in Triple-Negative Breast Cancer

July 21st 2015

Anti-HER2 Therapy for Metastatic Breast Cancer

July 21st 2015

PI3K Inhibition in Breast Cancer

July 21st 2015

Overcoming Endocrine Resistance in Breast Cancer

July 21st 2015

CDK4/6 Inhibition in Breast Cancer

July 21st 2015

Advancements in ER-Positive Breast Cancer

July 21st 2015

Guiding Treatment With Molecular Testing in Breast Cancer

July 21st 2015

Coleman Explains New Biomarker for PARP Inhibitors in Ovarian Cancer

July 17th 2015

Robert Coleman, MD, discusses a potential new biomarker for PARP inhibition in ovarian cancer that was examined in the ARIEL2 trial.

Global Perspective on the ASCO Annual Meeting

July 16th 2015

New Agents for Refractory Metastatic Colorectal Cancer

July 16th 2015

Immunotherapy in Colorectal Cancer

July 16th 2015

Maintenance Therapy in Colorectal Cancer

July 16th 2015

EGFR Inhibition in RAS Wild-Type Unresectable mCRC

July 16th 2015

Daily Aspirin for Colorectal Cancer Prevention

July 16th 2015

Impact of the SIRFLOX Study on CRC Management

July 16th 2015

Role of Surgery in Metastatic Colorectal Cancer

July 16th 2015